Kati Hanhineva1, Carl Brunius2, Agneta Andersson3, Matti Marklund4, Risto Juvonen5, Pekka Keski-Rahkonen5, Seppo Auriola5, Rikard Landberg2,6. 1. Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. 2. Department of Food Science, Uppsala BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden. 3. Department of Food, Nutrition and Dietetics, Uppsala University, Uppsala, Sweden. 4. Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala Univeristy, Uppsala, Sweden. 5. School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 6. Nutritional Epidemiology Unit, Institute of Environmental Medicine, Karolinska Insitutet, Stockholm, Sweden.
Abstract
SCOPE: Whole grain (WG) intake is associated with decreased risk of developing colorectal cancer, type 2 diabetes, and cardiovascular disease and its comorbidities. However, the role of specific grains is unclear. Moreover, intake of specific WG is challenging to measure accurately with traditional dietary assessment methods. Our aim was to use nontargeted metabolite profiling to discover specific urinary biomarkers for WG rye to objectively reflect intake under free-living conditions. METHODS AND RESULTS: WG rye intake was estimated by weighed food records, and 24 h urine collections were analyzed by LC-MS. Multivariate modeling was undertaken by repeated double cross-validated partial least squares regression against reported WG rye intake, which correlated well with multivariate prediction estimates (r = 0.67-0.80, p < 0.001), but not with intakes of WG wheat or oats. Hydroxyhydroxyphenyl acetamide sulfate, 3,5-dihydroxyphenylpropionic acid sulfate, caffeic acid sulfate, and hydroxyphenyl acetamide sulfate were among the 20 features that had the greatest potential as intake biomarkers of WG. In addition, three compounds exhibited MS/MS fragmentation of carnitine structures. CONCLUSION: With this nontargeted approach, we confirmed the specificity of alkylresorcinol metabolites as biomarkers for WG rye intake, but also discovered other compounds that should be evaluated as putative biomarkers in future studies.
SCOPE: Whole grain (WG) intake is associated with decreased risk of developing colorectal cancer, type 2 diabetes, and cardiovascular disease and its comorbidities. However, the role of specific grains is unclear. Moreover, intake of specific WG is challenging to measure accurately with traditional dietary assessment methods. Our aim was to use nontargeted metabolite profiling to discover specific urinary biomarkers for WG rye to objectively reflect intake under free-living conditions. METHODS AND RESULTS: WG rye intake was estimated by weighed food records, and 24 h urine collections were analyzed by LC-MS. Multivariate modeling was undertaken by repeated double cross-validated partial least squares regression against reported WG rye intake, which correlated well with multivariate prediction estimates (r = 0.67-0.80, p < 0.001), but not with intakes of WG wheat or oats. Hydroxyhydroxyphenyl acetamide sulfate, 3,5-dihydroxyphenylpropionic acid sulfate, caffeic acid sulfate, and hydroxyphenyl acetamide sulfate were among the 20 features that had the greatest potential as intake biomarkers of WG. In addition, three compounds exhibited MS/MS fragmentation of carnitine structures. CONCLUSION: With this nontargeted approach, we confirmed the specificity of alkylresorcinol metabolites as biomarkers for WG rye intake, but also discovered other compounds that should be evaluated as putative biomarkers in future studies.
Authors: Talha Rafiq; Sandi M Azab; Koon K Teo; Lehana Thabane; Sonia S Anand; Katherine M Morrison; Russell J de Souza; Philip Britz-McKibbin Journal: Adv Nutr Date: 2021-12-01 Impact factor: 8.701
Authors: Moritz Buck; Louise K J Nilsson; Carl Brunius; Roch K Dabiré; Richard Hopkins; Olle Terenius Journal: Sci Rep Date: 2016-03-10 Impact factor: 4.379
Authors: Millie Rådjursöga; Helen M Lindqvist; Anders Pedersen; Göran B Karlsson; Daniel Malmodin; Carl Brunius; Lars Ellegård; Anna Winkvist Journal: Nutr J Date: 2019-04-08 Impact factor: 3.271
Authors: Malin Barman; Fiona Murray; Angelina I Bernardi; Karin Broberg; Sven Bölte; Bill Hesselmar; Bo Jacobsson; Karin Jonsson; Maria Kippler; Hardis Rabe; Alastair B Ross; Fei Sjöberg; Nicklas Strömberg; Marie Vahter; Agnes E Wold; Ann-Sofie Sandberg; Anna Sandin Journal: BMJ Open Date: 2018-10-21 Impact factor: 2.692